Differential manipulation of the renin angiotensin system and epoietin requirements in maintenance haemodialysis patients
Authors:
- Peter J. GarrettPGPeter J. Garrett
- Linda StewartLSLinda Stewart
- Joyce LearyJLJoyce Leary
- Terence R. J. LappinTLTerence R. J. Lappin
Open Access
- 1 September 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 16 (9) , 1954-1955
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patientsNephrology Dialysis Transplantation, 1999
- Angiotensin-Converting Enzyme Inhibitors but Not Angiotensin II AT 1 Receptor Antagonists Affect Erythropoiesis in Patients with Anemia of End-Stage Renal DiseaseNephron, 1999
- Effect of losartan on haemoglobin concentration in renal transplant recipients - a retrospective analysisNephrology Dialysis Transplantation, 1997
- LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, REDUCES HEMATOCRITS IN KIDNEY TRANSPLANT RECIPIENTS WITH POSTTRANSPLANT ERYTHROCYTOSISTransplantation, 1997
- Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipientsTransplantation Proceedings, 1997
- Successful long-term treatment of post-transplant erythrocytosis with losartanNephrology Dialysis Transplantation, 1996
- Angiotensin-converting enzyme inhibitors and higher erythropoietin requirement in chronic haemodialysis patientsNephrology Dialysis Transplantation, 1995
- THE BENEFICIAL EFFECT OF ENALAPRIL ON ERYTHROCYTOSIS AFTER RENAL TRANSPLANTATIONTransplantation, 1993
- Enalapril-Associated Anemia in Renal Transplant Recipients Treated for HypertensionAmerican Journal of Kidney Diseases, 1991
- Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis PatientsAmerican Journal of Nephrology, 1984